These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30166700)

  • 1. BIOMEDICAL PREVENTION OF HIV IN WOMEN: CHALLENGES AND APPROACHES, WITH PARTICULAR REFERENCE TO THE VAGINAL MICROBIOME.
    Marrazzo JM
    Trans Am Clin Climatol Assoc; 2018; 129():63-73. PubMed ID: 30166700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.
    Heffron R; McClelland RS; Balkus JE; Celum C; Cohen CR; Mugo N; Bukusi E; Donnell D; Lingappa J; Kiarie J; Fiedler T; Munch M; Fredricks DN; Baeten JM;
    Lancet HIV; 2017 Oct; 4(10):e449-e456. PubMed ID: 28732773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women.
    Velloza J; Heffron R
    Curr HIV/AIDS Rep; 2017 Oct; 14(5):153-160. PubMed ID: 28812207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV.
    Farcasanu M; Kwon DS
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):30-38. PubMed ID: 29516267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microbiome and HIV prevention strategies in women.
    Abdool Karim SS; Passmore JS; Baxter C
    Curr Opin HIV AIDS; 2018 Jan; 13(1):81-87. PubMed ID: 29059077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women.
    Jespers V; van de Wijgert J; Cools P; Verhelst R; Verstraelen H; Delany-Moretlwe S; Mwaura M; Ndayisaba GF; Mandaliya K; Menten J; Hardy L; Crucitti T;
    BMC Infect Dis; 2015 Mar; 15():115. PubMed ID: 25879811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women.
    Mazibuko-Motau N; Sobia P; Xu J; Elsherbini JA; San JE; Lewis L; Mtshali A; Mzobe G; Ntuli L; Abdool Karim SS; Mansoor LE; Abdool Karim Q; Kwon DS; Archary D; Ngcapu S
    Sci Rep; 2022 Sep; 12(1):16187. PubMed ID: 36171447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism.
    Cheu RK; Gustin AT; Lee C; Schifanella L; Miller CJ; Ha A; Kim C; Rodriguez VJ; Fischl M; Burgener AD; Arnold KB; Alcaide ML; Klatt NR
    PLoS Pathog; 2020 Dec; 16(12):e1009024. PubMed ID: 33270801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different and diverse anaerobic microbiota were seen in women living with HIV with unsuppressed HIV viral load and in women with recurrent bacterial vaginosis: a cohort study.
    Elwood C; Albert A; McClymont E; Wagner E; Mahal D; Devakandan K; Quiqley BL; Pakzad Z; Yudin MH; Hill JE; Money D;
    BJOG; 2020 Jan; 127(2):250-259. PubMed ID: 31498547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human microbiome: implications for health and disease, including HIV infection.
    Schooley RT
    Top Antivir Med; 2018 Sep; 26(3):75-78. PubMed ID: 30384329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention.
    Bayigga L; Kateete DP; Anderson DJ; Sekikubo M; Nakanjako D
    Am J Obstet Gynecol; 2019 Feb; 220(2):155-166. PubMed ID: 30321529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
    Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
    J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the vaginal microbiome as a potential strategy to reduce heterosexual HIV transmission.
    Armstrong E; Kaul R; Cohen CR
    J Intern Med; 2023 Apr; 293(4):433-444. PubMed ID: 36544257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of the vaginal microbiota with HIV infection, bacterial vaginosis, and demographic factors.
    Chehoud C; Stieh DJ; Bailey AG; Laughlin AL; Allen SA; McCotter KL; Sherrill-Mix SA; Hope TJ; Bushman FD
    AIDS; 2017 Apr; 31(7):895-904. PubMed ID: 28121709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women.
    Gustin A; Cromarty R; Schifanella L; Klatt NR
    Semin Immunol; 2021 Jan; 51():101482. PubMed ID: 34120819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis.
    Mitchell C; Moreira C; Fredricks D; Paul K; Caliendo AM; Kurpewski J; Ingersoll J; Cu-Uvin S
    Infect Dis Obstet Gynecol; 2009; 2009():236919. PubMed ID: 19920869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women.
    Abdool Karim SS; Baxter C; Passmore JS; McKinnon LR; Williams BL
    J Int AIDS Soc; 2019 May; 22(5):e25300. PubMed ID: 31144462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial vaginosis, human papilloma virus and herpes viridae do not predict vaginal HIV RNA shedding in women living with HIV in Denmark.
    Wessman M; Thorsteinsson K; Jensen JS; Storgaard M; Rönsholt FF; Johansen IS; Pedersen G; Nørregård Nielsen L; Bonde J; Katzenstein TL; Weis N; Lebech AM
    BMC Infect Dis; 2017 May; 17(1):376. PubMed ID: 28569142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
    Doerflinger SY; Throop AL; Herbst-Kralovetz MM
    J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.
    Hoornenborg E; Prins M; Achterbergh RCA; Woittiez LR; Cornelissen M; Jurriaans S; Kootstra NA; Anderson PL; Reiss P; de Vries HJC; Prins JM; de Bree GJ;
    Lancet HIV; 2017 Nov; 4(11):e522-e528. PubMed ID: 28919303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.